Mode
Text Size
Log in / Sign up

Mobile-based cognitive behavioural therapy apps significantly reduce depressive symptoms in adolescents and young adultsMobile apps show promise for treating depression in young adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider mobile-based cognitive behavioural therapy apps as a moderately effective short-term intervention for depression.

This meta-analysis evaluated the efficacy of mobile-based cognitive behavioural therapy apps for treating depression in adolescents and young adults aged 13-25 years. The analysis included data from a systematic review of 1,896 participants to provide evidence on primary outcomes including depressive symptoms and secondary outcomes such as anxiety, quality of life, and usability.

The meta-analysis revealed a significant reduction in depressive symptoms compared with control groups (Cohen's d = -0.24; 95% confidence interval [-0.36, -0.13], p < 0.001). Additionally, improvements were observed in quality of life and usability (Cohen's d = 0.37), though no significant effects were found for anxiety (Cohen's d = -0.16). Safety data indicated lower adverse events in intervention groups (risk ratio = 0.68).

A noted limitation is the need for strategies to sustain long-term benefits of these interventions. These findings suggest that mobile-based cognitive behavioural therapy apps may be integrated into mental health service delivery as a moderately effective short-term intervention for this specific age group.

How this fits prior evidence

This finding extends existing evidence regarding digital and non-pharmacological interventions for depression. While Portable Digital Nature Experience was shown to reduce stress, anxiety, and depression scores, these results specifically highlight the efficacy of mobile-based cognitive behavioural therapy apps in a younger demographic (aged 13-25). This adds to a range of options including exercise for sleep quality and pharmacological treatments like oral ketamine or esketamine for various depressive conditions.

Living with depression as a teenager or young adult is incredibly hard. Finding the right support can feel like a daunting task, but new research suggests that technology might offer a helpful starting point. A large review of data involving over 1,000 participants found that mobile apps using cognitive behavioral therapy (a type of talk therapy focused on changing thought patterns) significantly reduced symptoms of depression.

While the study did not find significant changes in anxiety levels, it did show improvements in overall quality of life and how easy the tools were to use. These apps are considered a moderately effective way to help people in the short term. They also showed fewer reported adverse events compared to control groups.

It is important to remember that these findings focus on short-term results. Researchers noted that more work is needed to find ways to keep these benefits going over a long period of time. These tools are meant to support mental health services, not replace the care of a professional.

What this means for you:
Mobile apps using cognitive behavioral therapy can significantly reduce depression symptoms in young adults.

Common questions

Can mobile apps really help with depression?

Yes, the data shows that mobile apps using cognitive behavioral therapy can lead to a significant reduction in depressive symptoms for people aged 13 to 25. While these are considered moderately effective short-term interventions, they can be a helpful part of mental health care.

Are there any side effects to using these apps?

The study reported that adverse events were actually lower in the groups using the mobile apps compared to control groups. However, the research focused on short-term use, and more information is needed regarding long-term safety and benefits.

Do these apps help with anxiety too?

While the app showed significant results for depression and improved quality of life, the study did not find any significant effects on anxiety symptoms for the participants involved.

Study Details

Study typeMeta analysis
Sample sizen = 1,896
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
OBJECTIVE: Adolescent depression is a significant public health concern, with prevalence rates increasing globally over recent years. Mobile-based cognitive behavioural therapy applications are increasingly used to address adolescent depression, but their effectiveness remains unclear. This study evaluated the impact of mobile-based cognitive behavioural therapy apps on depressive symptoms in this population, with secondary analyses examining anxiety, quality of life, usability and adverse events. METHOD: A systematic review identified 10 randomized controlled trials containing 1896 participants. These studies were published since 2014 and assessed the effects of mobile-based cognitive behavioural therapy for depression in adolescents (aged 13-25 years). Databases searched included MEDLINE, PsycINFO, Embase, PubMed and the Cochrane Library. Subsequent meta-analysis was conducted on nine studies ( = 1127). Studies reporting depressive symptom outcomes were included in meta-analyses using a random-effects model. RESULTS: Meta-analysis showed a significant reduction in depressive symptoms compared with the control groups (Cohen's  = -0.24; 95% confidence interval = [-0.36, -0.13],  < 0.001), with negligible heterogeneity ( = 0%). Meta-regression showed no significant association between follow-up duration and effect size. No significant effects were found for anxiety ( = -0.16), but improvements were observed in quality of life ( = 0.37) and usability ( = 0.37). Adverse event rates were lower in the intervention groups (risk ratio = 0.68). CONCLUSION: Mobile-based cognitive behavioural therapy is a moderately effective short-term intervention for adolescent and young adult depression. These findings support its integration into mental health service delivery, although strategies to sustain long-term benefits are needed.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.